OpenVSafe by OpenVAERS
Search V-safe

XX7-16067-92122

2 vaccinations 7 coded responses 21 check-ins 7 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
923 / CA
Registered
2021-01-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-15
    Dose 1 — Moderna
  2. 2021-01-16
    Registered in v-safe
  3. 2021-01-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness
    Adult check-in
  4. 2021-01-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness
    Adult check-in
  5. 2021-01-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-01-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Nausea
    Adult check-in
  7. 2021-01-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-22
    Health check-in — 7 day, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-31
    Health check-in — 14 day, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-06
    Health check-in — 21 day, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-12
    Dose 2 — Moderna
  12. 2021-02-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Adverse reaction — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  13. 2021-02-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Adverse reaction — Feeling: Fair · Site: Pain · Headache, Muscle or body aches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  14. 2021-02-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Swelling
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  15. 2021-02-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  16. 2021-02-19
    Survey response — 7 day, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  17. 2021-02-26
    Health check-in — 14 day, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-03-06
    Health check-in — 21 day, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-03-14
    Survey response — 28 day, dose 2
    MedDRA: Arthralgia, Joint swelling — Feeling: Good
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  20. 2021-03-20
    Health check-in — 35 day, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-26
    Health check-in — 42 day, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-14
    Health check-in — 3 month, dose 2
    Feeling: Fair
    Adult check-in
  23. 2021-08-13
    Health check-in — 6 month, dose 2
    Feeling: Good
    Adult check-in
  24. 2022-02-12
    Survey response — 12 month, dose 2
    MedDRA: SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11 · check-in answers available
  25. 2022-02-12
    Report sent to call center — 12 month, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  26. 2022-02-16
  27. 2022-02-18
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

DoseDateManufacturerCo-administered
12021-01-15Moderna
22021-02-12Moderna

Call center

ReportedOutcomeVAERS-related outcome
2022-02-12 Successful
2022-02-18
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 4

Systemic reaction (other): These symptoms happened yesterday, but I didn't get a prompt yesterday.

Systemic reaction (other): These symptoms are being reported for 14 Feb 2021

Systemic reaction (other): swollen/tender ipsilateral supraclavicular lymph node (This information is accurate for yesterday, 15 Feb 2021)

Systemic reaction (other): swollen ipsilateral supraclavicular lymph nodes for both today and yesterday

Systemic reaction (other): mildly swollen ipsalateral supraclavicular lymph nodes

Release 5

Symptoms: Mild joint swelling in my right hand, in the index finger and thumb. Somewhat painful.

Release 11

Symptoms: Upper respiratory infection - not COVID confirmed by PCR and antigen test

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia ✓ ✓ ✓
SDJoint swelling ✓ ✓ ✓
SDSARS-CoV-2 test negative · · ✓
SDUpper respiratory tract infection · · ✓
SROAdverse reaction ✓ ✓ ✓
SROLymph node pain ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release